Showing results (2891-2900 of 9,906) with videos related to

Sort By:
Pageof 991
Bone Marrow Transplantation|June 1, 1995
Analysis of peripheral blood progenitor cells demonstrates limitations of minimal residual disease diagnosis in a case of acute promyelocytic leukemiaH I Karlic, H Mühlberger, B G Pavlova, et al.
Bone Marrow Transplantation|July 1, 1995
High-dose cyclosporine and corticosteroids for prophylaxis of acute and chronic graft-versus-host diseaseT L Schwinghammer, E J Bloom, C S Rosenfeld, et al.
Bone Marrow Transplantation|July 1, 1995
Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantationC K Lee, R D Gingrich, R J Hohl, et al.
Bone Marrow Transplantation|July 1, 1995
Allogeneic BMT in a patient with CML and prior disseminated infection by mycobacterium avium complexG Hermida, C Richard, J Baro, et al.
Bone Marrow Transplantation|July 1, 1995
Severe hepatotoxicity from granulocyte-macrophage colony-stimulating factor administered after autologous bone marrow transplantationH M Prince, M Cheng, R G Cameron, et al.
Bone Marrow Transplantation|July 1, 1995
Peripheral blood stem cell transplantation after high-dose therapy in patients with malignant lymphoma: a retrospective comparison with autologous bone marrow transplantationS Ager, M A Scott, P Mahendra, et al.
Bone Marrow Transplantation|July 1, 1995
DHAP regimen plus G-CSF as salvage therapy and priming for blood progenitor cell collection in patients with poor prognosis lymphomaA Olivieri, M Offidani, L Ciniero, et al.
Bone Marrow Transplantation|July 1, 1995
Natural killer cell regeneration after transplantation with mafosfamide purged autologous bone marrowC Almici, L Manoni, C Carlo-Stella, et al.
Bone Marrow Transplantation|August 1, 1995
Association of increased bronchoalveolar lavage fluid albumin and serum beta 2-microglobulin with pulmonary complications after allogeneic bone marrow transplantationE Kreuzfelder, K Quabeck, M Braun, et al.
Bone Marrow Transplantation|August 1, 1995
In vitro LAK (lymphokine activated killer) activity following autologous peripheral blood stem cell is significantly greater than that following autologous bone marrow and allogeneic bone marrow transplantationC Fegan, H Thomas, R Bailey-Wood, et al.
Pageof 991